Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

Peptides for Muscle Building: Comparison of Mechanisms

This table compares the primary peptide classes studied for anabolic and recovery applications. Their receptor targets, mechanisms, and documented effects differ significantly. GH Secretagogues (GHRP-2, Ipamorelin, Hexarelin) Stimulate pulsatile endogenous GH

This comparison does not assign a generated winner or score.

  • This table compares the primary peptide classes studied for anabolic and recovery applications. Their receptor targets, mechanisms, and documented effects differ significantly.
  • GH Secretagogues (GHRP-2, Ipamorelin, Hexarelin)
  • Stimulate pulsatile endogenous GH release through ghrelin receptor activation
  • GHS-R1a (ghrelin receptor) on pituitary cells
  • 3–7× GH elevation, downstream IGF-1 rise, enhanced lipolysis, improved sleep quality
  • Muscle protein synthesis studies, body composition research, aging intervention trials
  • Most evidence-backed class for anabolic signaling. Synergistic with GHRH analogs
  • GHRH Analogs (CJC-1295, Modified GRF 1-29)
  • Amplify GH release through GHRH receptor stimulation; extended half-life with DAC modification
  • GHRH receptor on anterior pituitary
  • Sustained GH elevation over 6–8 days (with DAC), synergistic with GHS compounds
  • Long-term growth hormone studies, metabolic research, cachexia models
  • Best combined with GHS peptides. Mono-therapy less effective than combo protocols
  • IGF-1 Variants (IGF-1 LR3, DES 1-3 IGF-1)
  • Direct IGF-1 receptor activation, bypassing GH pathway entirely
  • IGF-1 receptor on skeletal muscle and other tissues
  • Localized muscle hypertrophy, increased satellite cell activation, reduced IGFBP binding
  • Muscle wasting research, site-specific hypertrophy studies
  • Potent but less studied than GH secretagogues. Higher risk of off-target effects
  • Collagen Synthesis Peptides (BPC-157, TB-500)
  • Promote angiogenesis, collagen production, and tissue repair; no direct anabolic signaling
  • Multiple. Actin-binding proteins, VEGF pathways, fibroblast activation
  • Accelerated tendon/ligament healing, reduced inflammation, improved joint integrity
  • Injury recovery models, chronic tendinopathy research, post-surgical healing
  • Adjunct to anabolic peptides. Support structural adaptation but don't drive hypertrophy alone
  • Ghrelin Mimetics (MK-677)
  • Oral GH secretagogue. Mimics ghrelin to stimulate GH release without injection
  • GHS-R1a (same as GHRP class)
  • 24-hour GH elevation, appetite stimulation, improved bone density markers
  • Oral bioavailability studies, elderly sarcopenia research, appetite regulation
  • Convenient oral option. Less peak GH than injectable GHS but more sustained baseline elevation
More references

Related material